0001209191-23-045499.txt : 20230814
0001209191-23-045499.hdr.sgml : 20230814
20230814080009
ACCESSION NUMBER: 0001209191-23-045499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WORLAND STEPHEN T
CENTRAL INDEX KEY: 0001283307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39866
FILM NUMBER: 231166382
MAIL ADDRESS:
STREET 1: 9050 CAMINO SANTA FE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc.
CENTRAL INDEX KEY: 0001828522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853306396
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: (858) 925-8215
MAIL ADDRESS:
STREET 1: 142 NORTH CEDROS AVENUE, SUITE B
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER COMPANY:
FORMER CONFORMED NAME: Locust Walk Acquisition Corp.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-11
0
0001828522
eFFECTOR Therapeutics, Inc.
EFTR
0001283307
WORLAND STEPHEN T
C/O EFFECTOR THERAPEUTICS, INC.
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH
CA
92075
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-08-11
4
M
0
33799
0.52
A
261225
D
Common Stock
562339
I
By trust
Stock Option (Right to Buy)
0.52
2023-08-11
4
M
0
33799
0.00
D
2023-12-16
Common Stock
33799
0
D
The stock option vests 25% on December 17, 2014, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
2023-08-14